and when those 300,000 share blocks are being sold (there was another yesterday), who is on the other side buying? it has to be Ted - right?
My next buy is at $1.45.
I think you may be going overboard with your assessment of the situation. But, it is true, we need to wait for more information.
"...primarily due to the time necessary to complete the review of certain complex, multi-element contracts. The company may have a material weakness in its internal controls over financial reporting related to certain of these multi-element contracts..."
It is focused on these specific contracts. It doesn't sound like there are lots of them, just that there is some aspect of some of them that makes the accounting more involved.
I previously mentioned my thoughts, yesterday I saw my vision on the shelf at Walgreens.
Go and google for AllergEase.
There it is - the solution to our problem.
Executed better than expected for the quarter. Decent outlook. Next quarter has losses lower than current estimate. CEO is very strong and has the right plan for moving forward.
This is a turnaround play - it's expected that there would be a few soft quarters. The company is doing what's necessary to return to long-term growth/profitability.
Book to bill 1.26
The way to play these is by buying slowly on the way down - don't shoot your wad all at once or you will be extremely disappointed if you don't catch the absolute bottom.
Earnings and press release speak for themselves.
Red ink to flow, lots more shares to be issued and thus dilution. More legal fees coming.
Thanks for the gains/profits over the past year Ted - I really appreciate it, but I'm not going along for this ride with you.
Good luck to all who stay - I wish you nothing but success with this investment and all others.
"Sidoti seems to be giving us a warning about possible lower prices. Others here may disagree and dislike the fact that I'm mentioning it but just by reviewing their web site, they seem to be under no pressure to do anything but provide research. "
What happened is perfectly clear. Sidoti did nothing but read the headline and shoot from the hip, plain and simple. If you give credence to that type of "coverage", then more power to you. What I've learned is that it's the kind of stuff that shock journalism is made of. I think back to when another big firm put a similar type of rating on Royal Caribbean Cruise Lines when it was trading at $5 not so many years ago. The company and stock price performance since that day speaks for itself.
So, if you look to such dramatization from the only firm providing coverage, that they provided absolutely no details of specifics why they issued their downgrade and price target before having any details from the company, then again, soak it all in.
You will see Sidoti move back to a buy rating with the prior $2 price target they had when the company finalizes and submits the filings - with absolutely no material changes having taken place during the period. I will bank on it.
Director who only held a small number of shares to begin with.
If Popielec, Fain, or Whitmore/Sunray sell shares I might be more interested.
I don't think this could be a huge problem attributable (only) to the CFO as he was in his position only since December and obviously this was caught in the March quarter with the full year audit.
another 300,000 share block was traded today.
Maybe Dutchess is selling off what was previously put to them under the last agreement?
Whatever, it would be nice to get some clarification on it.
"If we double 6 month revenues we'll have about $61 million for the year, 2% to 3% would be operating loss of about $1.5 million and currently we are at a loss of $2.4 million..."
As indicated on the call, back half is expected to be about $40 million revenues and about $70 million total for the year. So, 2% to 3% is a loss of about $1.75 million - again, there will be profitability the remainder of the year. As also indicated, this is the conservative view. They are successfully diversifying into commercial areas to compensate for decline in government business. When government business comes, it will be icing on the cake.
Now is the time to be buying these small banks during the summer doldrums (for banking stocks). This happens most every year. However, this year it is even more a time to be buying them in a big way. Interest rates will trend higher next year, and when that (finally) happens bank earnings increase! Most people are looking the other way and do not understand these basic concepts.
In the mean time, slowly acquire shares if the trend lower. Diversify across multiple names. Look more towars book value and those trading near or below compared to those wildly above book value. Make exceptions for those carrying low debt loads, growing top/bottom line, and paying good/stable/increasing dividends. Lastly, those that are potential acquisition targets (like AROW) should be on the top of the list for accumulation.
Yes, I saw that - I'm suspecting they may post a small loss for the quarter...probably will take some one time charges for closing the two branch locations and probably some for acquisition and beginning of Slavie integration.
From the wording, I'm just guessing that it may be a revenue recognition issue...the sales are all there, just a matter of when they recognize the revenue for accounting purposes. If this is the case, then some sales may be moved between quarters.